Title Human H 7 N 9 virus induces a more pronounced pro-inflammatory cytokine but an attenuated interferon response in human bronchial epithelial cells when compared with an epidemiologically-linked chicken H 7 N 9 virus
暂无分享,去创建一个
K. To | Kwok-Hung Chan | J. Chan | Honglin Chen | K. Yuen | A. J. Zhang | S. Lau | Patrick C Y Woo | C. C. Lau
[1] K. Zen,et al. Pro-inflammatory cytokine dysregulation is associated with novel avian influenza A (H7N9) virus in primary human macrophages. , 2016, The Journal of general virology.
[2] K. To,et al. Suboptimal Humoral Immune Response against Influenza A(H7N9) Virus Is Related to Its Internal Genes , 2015, Clinical and Vaccine Immunology.
[3] Shigui Yang,et al. The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes , 2015, Scientific Reports.
[4] T. Tumpey,et al. A(H7N9) Virus Results in Early Induction of Proinflammatory Cytokine Responses in both Human Lung Epithelial and Endothelial Cells and Shows Increased Human Adaptation Compared with Avian H5N1 Virus , 2015, Journal of Virology.
[5] J. Shelhamer,et al. Validation of Normal Human Bronchial Epithelial Cells as a Model for Influenza A Infections in Human Distal Trachea , 2015, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[6] Ha T. Nguyen,et al. Characterization of drug-resistant influenza A(H7N9) variants isolated from an oseltamivir-treated patient in Taiwan. , 2015, The Journal of infectious diseases.
[7] Qun Li,et al. Poultry farms as a source of avian influenza A (H7N9) virus reassortment and human infection , 2015, Scientific Reports.
[8] T. Yeo,et al. Avian Influenza (H7N9) Virus Infection in Chinese Tourist in Malaysia, 2014 , 2015, Emerging infectious diseases.
[9] Qibin Zhang,et al. A comprehensive collection of systems biology data characterizing the host response to viral infection , 2014, Scientific Data.
[10] K. To,et al. Avian Influenza A H7N9 Virus Induces Severe Pneumonia in Mice without Prior Adaptation and Responds to a Combination of Zanamivir and COX-2 Inhibitor , 2014, PloS one.
[11] M. Katze,et al. H7N9 and Other Pathogenic Avian Influenza Viruses Elicit a Three-Pronged Transcriptomic Signature That Is Reminiscent of 1918 Influenza Virus and Is Associated with Lethal Outcome in Mice , 2014, Journal of Virology.
[12] J. Chan,et al. Viral lung infections: Epidemiology, virology, clinical features, and management of avian influenza A(H7N9) , 2014, Current opinion in pulmonary medicine.
[13] K. To,et al. Unique reassortant of influenza A(H7N9) virus associated with severe disease emerging in Hong Kong , 2014, Journal of Infection.
[14] M. Katze,et al. Transcriptomic Characterization of the Novel Avian-Origin Influenza A (H7N9) Virus: Specific Host Response and Responses Intermediate between Avian (H5N1 and H7N7) and Human (H3N2) Viruses and Implications for Treatment Options , 2014, mBio.
[15] T. Allen,et al. Interleukin 8 and acute lung injury. , 2014, Archives of pathology & laboratory medicine.
[16] Q. Jin,et al. Human Antibody Responses to Avian Influenza A(H7N9) Virus, 2013 , 2014, Emerging infectious diseases.
[17] Ruifu Yang,et al. Dynamic reassortments and genetic heterogeneity of the human-infecting influenza A (H7N9) virus , 2014, Nature Communications.
[18] K. To,et al. Avian-origin influenza A(H7N9) infection in influenza A(H7N9)-affected areas of China: a serological study. , 2014, The Journal of infectious diseases.
[19] T. Kuiken,et al. Pathogenesis of influenza-induced acute respiratory distress syndrome. , 2014, The Lancet. Infectious diseases.
[20] P. Doherty,et al. Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection , 2013, Proceedings of the National Academy of Sciences.
[21] Zheng Xing,et al. Cytokine and chemokine levels in patients infected with the novel avian influenza A (H7N9) virus in China. , 2013, The Journal of infectious diseases.
[22] Kwok-Hung Chan,et al. Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment. , 2013, The Journal of general virology.
[23] A. Gruber,et al. The Novel Human Influenza A(H7N9) Virus Is Naturally Adapted to Efficient Growth in Human Lung Tissue , 2013, mBio.
[24] J. Chan,et al. The emergence of influenza A H7N9 in human beings 16 years after influenza A H5N1: a tale of two cities , 2013, The Lancet Infectious Diseases.
[25] K. To,et al. Clinical, virological, and histopathological manifestations of fatal human infections by avian influenza A(H7N9) virus. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[26] Guohua Deng,et al. H7N9 Influenza Viruses Are Transmissible in Ferrets by Respiratory Droplet , 2013, Science.
[27] Y. Guan,et al. Tropism and innate host responses of a novel avian influenza A H7N9 virus: an analysis of ex-vivo and in-vitro cultures of the human respiratory tract , 2013, The Lancet Respiratory Medicine.
[28] Noriko Kishida,et al. Characterization of H7N9 influenza A viruses isolated from humans , 2013, Nature.
[29] Huachen Zhu,et al. Pathogenicity of the Novel A/H7N9 Influenza Virus in Mice , 2013, mBio.
[30] Jie Dong,et al. Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus. , 2018 .
[31] Wenjun Song,et al. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome , 2013, The Lancet.
[32] K. To,et al. Leptin mediates the pathogenesis of severe 2009 pandemic influenza A(H1N1) infection associated with cytokine dysregulation in mice with diet-induced obesity. , 2013, The Journal of infectious diseases.
[33] K. To,et al. Differential Cell Line Susceptibility to the Emerging Novel Human Betacoronavirus 2c EMC/2012: Implications for Disease Pathogenesis and Clinical Manifestation , 2013, The Journal of infectious diseases.
[34] Honglin Chen,et al. Avian influenza A H5N1 virus: a continuous threat to humans , 2012, Emerging Microbes & Infections.
[35] Herman Tse,et al. Two Years after Pandemic Influenza A/2009/H1N1: What Have We Learned? , 2012, Clinical Microbiology Reviews.
[36] R. Sugrue,et al. Activation of Type I and III Interferon Signalling Pathways Occurs in Lung Epithelial Cells Infected with Low Pathogenic Avian Influenza Viruses , 2012, PloS one.
[37] N. Cox,et al. Pathogenesis and transmission of swine origin A(H3N2)v influenza viruses in ferrets , 2012, Proceedings of the National Academy of Sciences.
[38] Chengjun Li,et al. Conserved host response to highly pathogenic avian influenza virus infection in human cell culture, mouse and macaque model systems , 2011, BMC Systems Biology.
[39] K. To,et al. The Lower Serum Immunoglobulin G2 Level in Severe Cases than in Mild Cases of Pandemic H1N1 2009 Influenza Is Associated with Cytokine Dysregulation , 2010, Clinical and Vaccine Immunology.
[40] V. Chow,et al. MCP-1 antibody treatment enhances damage and impedes repair of the alveolar epithelium in influenza pneumonitis. , 2010, American journal of respiratory cell and molecular biology.
[41] Samson S. Y. Wong,et al. Delayed Clearance of Viral Load and Marked Cytokine Activation in Severe Cases of Pandemic H1N1 2009 Influenza Virus Infection , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[42] P. Woo,et al. Cytokine Profiles Induced by the Novel Swine-Origin Influenza A/H1N1 Virus: Implications for Treatment Strategies , 2010, The Journal of infectious diseases.
[43] J. Chan,et al. Differential susceptibility of different cell lines to swine-origin influenza A H1N1, seasonal human influenza A H1N1, and avian influenza A H5N1 viruses. , 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[44] K. Hartshorn,et al. Differentiated Human Alveolar Type II Cells Secrete Antiviral IL-29 (IFN-λ1) in Response to Influenza A Infection1 , 2009, The Journal of Immunology.
[45] Yi Guan,et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia , 2006, Nature Medicine.